Taiyen Biotech Co., Ltd. (1737.TW)
TWD 32.15
(-0.31%)
TWD 32.15
(-0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 526.4 Million | 580.68 Million | 600.07 Million | 339.35 Million | 330.8 Million | 449.83 Million |
| Net Income | 300.38 Million | 530.58 Million | 509.91 Million | 464.03 Million | 428.54 Million | 531.59 Million |
| Depreciation & Amortization | 185.8 Million | 194.94 Million | 189.66 Million | 186 Million | 171.34 Million | 170.21 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 10.48 Million | -4.39 Million | -8.97 Million | -211.6 Million | -155.56 Million | -58.68 Million |
| Other non-cash items | 29.72 Million | -140.45 Million | -90.52 Million | -99.08 Million | -113.51 Million | -193.28 Million |
| Investing Cash Flow | -374.2 Million | -229.63 Million | -351.38 Million | -252.44 Million | -133.12 Million | -101.09 Million |
| Investments in PPE | -345.13 Million | -246.6 Million | -390.81 Million | -267.89 Million | -284.25 Million | -298.48 Million |
| Acquisitions | - | -12.18 Million | 7.83 Million | 5.67 Million | 22.18 Million | 126 Thousand |
| Investment purchases | -30 Million | -1.54 Million | -35.54 Million | -90 Million | -136.8 Million | -98.2 Million |
| Sales/Maturities of investments | 709 Thousand | 1.26 Million | 62.93 Million | 83.16 Million | 264.2 Million | 124.7 Million |
| Other Investing Activities | 216 Thousand | 29.42 Million | 4.2 Million | 16.61 Million | 1.54 Million | 170.75 Million |
| Financing Cash Flow | -236.17 Million | -547.97 Million | -28.43 Million | -180.67 Million | -277.8 Million | -329.76 Million |
| Debt repayment | -50.91 Million | -712.58 Million | -362.36 Million | -52.14 Million | -103.6 Million | -13.17 Million |
| Dividends payments | -300 Million | -300 Million | -270 Million | -300 Million | -360 Million | -300 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 114.74 Million | 464.6 Million | 603.92 Million | 171.46 Million | 185.79 Million | -29.76 Million |
| Accounts receivables | -86.5 Million | 107.32 Million | -216.73 Million | -191.69 Million | -120.66 Million | -57.64 Million |
| Accounts payables | 21.34 Million | -104.59 Million | 187.74 Million | 93.86 Million | 54.08 Million | -18.69 Million |
| Inventory | -2.89 Million | -25.23 Million | -97.11 Million | -8.54 Million | -32.5 Million | 20.34 Million |
| Other working capital | 78.54 Million | 18.11 Million | 117.13 Million | -105.23 Million | -56.48 Million | -79.02 Million |
| Cash at beginning of period | 1.52 Billion | 1.72 Billion | 1.5 Billion | 1.59 Billion | 1.67 Billion | 1.66 Billion |
| Cash at end of period | 1.44 Billion | 1.52 Billion | 1.72 Billion | 1.5 Billion | 1.59 Billion | 1.67 Billion |
| Capital Expenditure | -345.13 Million | -246.6 Million | -390.81 Million | -267.89 Million | -284.25 Million | -298.48 Million |
| Effect of forex changes on cash | -385 Thousand | 242 Thousand | -115 Thousand | 301 Thousand | -562 Thousand | -379 Thousand |
| Net cash flow / Change in cash | -84.36 Million | -196.68 Million | 220.14 Million | -93.46 Million | -80.68 Million | 18.59 Million |
| Free Cash Flow | 181.26 Million | 334.08 Million | 209.26 Million | 71.46 Million | 46.55 Million | 151.34 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 98.88 Million | 120.26 Million | 300.38 Million | 2.76 Million | 184.07 Million | 20.19 Million |
| Depreciation & Amortization | 51.59 Million | 51.21 Million | 185.8 Million | 37.58 Million | 49.66 Million | 48.97 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -38.64 Million | -149.38 Million | 10.48 Million | 123.44 Million | -61.86 Million | 63.74 Million |
| Other non-cash items | 154.19 Million | -7.66 Million | 29.72 Million | 39.43 Million | -28.73 Million | -34.64 Million |
| Investing Cash Flow | -162.13 Million | -24.9 Million | -374.2 Million | -68.78 Million | -133.57 Million | -96.84 Million |
| Investments in PPE | -111.35 Million | -34.44 Million | -345.13 Million | -58.9 Million | -121.24 Million | -106.14 Million |
| Acquisitions | - | - | - | - | 6.88 Million | 7.07 Million |
| Investment purchases | -50 Million | - | -30 Million | -10 Million | -20 Million | 135 Thousand |
| Sales/Maturities of investments | -875 Thousand | 889 Thousand | 709 Thousand | -227 Thousand | 8000.00 | 928 Thousand |
| Other Investing Activities | 96 Thousand | -888 Thousand | 216 Thousand | 351 Thousand | 772 Thousand | 1.15 Million |
| Financing Cash Flow | 37.99 Million | 28.92 Million | -236.17 Million | -33.63 Million | -243.07 Million | 39.66 Million |
| Debt repayment | -44.74 Million | -26.17 Million | -50.91 Million | -35.92 Million | -32.16 Million | -22.16 Million |
| Dividends payments | - | - | -300 Million | - | -300 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.18 Million | 6.22 Million | 114.74 Million | 2.28 Million | 89.09 Million | 61.82 Million |
| Accounts receivables | -844 Thousand | -5.97 Million | -86.5 Million | 43.71 Million | -74.61 Million | 11.6 Million |
| Accounts payables | -32.43 Million | 15.18 Million | 21.34 Million | -28.4 Million | -21.62 Million | 71.46 Million |
| Inventory | -30.78 Million | 1.19 Million | -2.89 Million | 15.18 Million | 2.45 Million | -35.06 Million |
| Other working capital | 25.41 Million | -136.38 Million | 78.54 Million | 92.95 Million | 31.92 Million | 15.73 Million |
| Cash at beginning of period | 1.5 Billion | 1.44 Billion | 1.52 Billion | 1.34 Billion | 1.57 Billion | 1.53 Billion |
| Cash at end of period | 1.48 Billion | 1.5 Billion | 1.44 Billion | 1.44 Billion | 1.34 Billion | 1.57 Billion |
| Capital Expenditure | -111.35 Million | -34.44 Million | -345.13 Million | -58.9 Million | -121.24 Million | -106.14 Million |
| Effect of forex changes on cash | 182 Thousand | 399 Thousand | -385 Thousand | -425 Thousand | 623 Thousand | -681 Thousand |
| Net cash flow / Change in cash | -25.17 Million | 64.02 Million | -84.36 Million | 100.38 Million | -232.88 Million | 40.41 Million |
| Free Cash Flow | -12.57 Million | 25.16 Million | 181.26 Million | 144.32 Million | 21.89 Million | -7.86 Million |
9627
6491
5546
PADI
OTLK
KIRLPNU